
Anne Marie Falk
Examiner (ID: 427)
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 685 |
| Issued Applications | 242 |
| Pending Applications | 153 |
| Abandoned Applications | 292 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6755312
[patent_doc_number] => 20030003089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'Tissue engineered cardiac constructs'
[patent_app_type] => new
[patent_app_number] => 10/141768
[patent_app_country] => US
[patent_app_date] => 2002-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7949
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20030003089.pdf
[firstpage_image] =>[orig_patent_app_number] => 10141768
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/141768 | Tissue engineered cardiac constructs | May 9, 2002 | Abandoned |
Array
(
[id] => 586049
[patent_doc_number] => 07446239
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-04
[patent_title] => 'SCA2 knockout animal and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/141541
[patent_app_country] => US
[patent_app_date] => 2002-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10273
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/446/07446239.pdf
[firstpage_image] =>[orig_patent_app_number] => 10141541
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/141541 | SCA2 knockout animal and methods of use | May 6, 2002 | Issued |
Array
(
[id] => 6792516
[patent_doc_number] => 20030087860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Methods for sexing non-human mammals'
[patent_app_type] => new
[patent_app_number] => 10/137706
[patent_app_country] => US
[patent_app_date] => 2002-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4479
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087860.pdf
[firstpage_image] =>[orig_patent_app_number] => 10137706
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/137706 | Methods for sexing non-human mammals | May 2, 2002 | Abandoned |
Array
(
[id] => 6869999
[patent_doc_number] => 20030082688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Spoil protein and nucleic acid molecules and uses therefor'
[patent_app_type] => new
[patent_app_number] => 10/126560
[patent_app_country] => US
[patent_app_date] => 2002-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 44429
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082688.pdf
[firstpage_image] =>[orig_patent_app_number] => 10126560
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/126560 | Spoil protein and nucleic acid molecules and uses therefor | Apr 18, 2002 | Abandoned |
Array
(
[id] => 6846267
[patent_doc_number] => 20030165434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Delivery of polynucleotide agents to the central nervous system'
[patent_app_type] => new
[patent_app_number] => 10/126060
[patent_app_country] => US
[patent_app_date] => 2002-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25762
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20030165434.pdf
[firstpage_image] =>[orig_patent_app_number] => 10126060
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/126060 | Delivery of polynucleotide agents to the central nervous system | Apr 18, 2002 | Abandoned |
Array
(
[id] => 6741789
[patent_doc_number] => 20030159158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Method for identifying an agonist of neuronal calcium sensor-1 (NCS-1), for therapy of CNS disorders'
[patent_app_type] => new
[patent_app_number] => 10/124334
[patent_app_country] => US
[patent_app_date] => 2002-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 29033
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20030159158.pdf
[firstpage_image] =>[orig_patent_app_number] => 10124334
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/124334 | Method for identifying an agonist of neuronal calcium sensor-1 (NCS-1), for therapy of CNS disorders | Apr 16, 2002 | Issued |
Array
(
[id] => 5859840
[patent_doc_number] => 20020123467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Therapeutic composition comprising the KAL protein and use of the KAL protein for the treatment of retinal, renal, neuronal and neural injury'
[patent_app_type] => new
[patent_app_number] => 10/119714
[patent_app_country] => US
[patent_app_date] => 2002-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 15441
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20020123467.pdf
[firstpage_image] =>[orig_patent_app_number] => 10119714
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/119714 | Therapeutic composition comprising the KAL protein and use of the KAL protein for the treatment of retinal, renal, neuronal and neural injury | Apr 10, 2002 | Abandoned |
Array
(
[id] => 748593
[patent_doc_number] => 07022321
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-04
[patent_title] => 'Use of marrow-derived glial progenitor cells as gene delivery vehicles into the central nervous system'
[patent_app_type] => utility
[patent_app_number] => 10/122703
[patent_app_country] => US
[patent_app_date] => 2002-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 6058
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/022/07022321.pdf
[firstpage_image] =>[orig_patent_app_number] => 10122703
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/122703 | Use of marrow-derived glial progenitor cells as gene delivery vehicles into the central nervous system | Apr 10, 2002 | Issued |
Array
(
[id] => 6261718
[patent_doc_number] => 20020187921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-12
[patent_title] => 'Transgenic zebrafish models for neurodegenerative disease'
[patent_app_type] => new
[patent_app_number] => 10/116723
[patent_app_country] => US
[patent_app_date] => 2002-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13986
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20020187921.pdf
[firstpage_image] =>[orig_patent_app_number] => 10116723
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/116723 | Transgenic zebrafish models for neurodegenerative disease | Apr 3, 2002 | Abandoned |
Array
(
[id] => 6774667
[patent_doc_number] => 20030018005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Gene therapy of diseases associated with the immune system, using a cell-specific active compound which is regulated by the cell cycle'
[patent_app_type] => new
[patent_app_number] => 10/112953
[patent_app_country] => US
[patent_app_date] => 2002-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 22852
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20030018005.pdf
[firstpage_image] =>[orig_patent_app_number] => 10112953
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/112953 | Gene therapy of diseases associated with the immune system, using a cell-specific active compound which is regulated by the cell cycle | Apr 1, 2002 | Abandoned |
Array
(
[id] => 6813550
[patent_doc_number] => 20030073100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Method of identifying renalgenerative agents using differential gene expression'
[patent_app_type] => new
[patent_app_number] => 10/113312
[patent_app_country] => US
[patent_app_date] => 2002-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8440
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073100.pdf
[firstpage_image] =>[orig_patent_app_number] => 10113312
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/113312 | Method of identifying renalgenerative agents using differential gene expression | Mar 31, 2002 | Abandoned |
Array
(
[id] => 6720652
[patent_doc_number] => 20030054340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Neural tracing with a conditional herpesvirus and methods and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/109534
[patent_app_country] => US
[patent_app_date] => 2002-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 18836
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20030054340.pdf
[firstpage_image] =>[orig_patent_app_number] => 10109534
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/109534 | Neural tracing with a conditional herpesvirus and methods and uses thereof | Mar 27, 2002 | Abandoned |
Array
(
[id] => 6752194
[patent_doc_number] => 20030046715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'H2-O modified transgenic animals'
[patent_app_type] => new
[patent_app_number] => 10/109165
[patent_app_country] => US
[patent_app_date] => 2002-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12283
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20030046715.pdf
[firstpage_image] =>[orig_patent_app_number] => 10109165
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/109165 | H2-O modified transgenic animals | Mar 26, 2002 | Abandoned |
Array
(
[id] => 363692
[patent_doc_number] => 07482506
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-01-27
[patent_title] => 'Ras p27 mouse models and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/472057
[patent_app_country] => US
[patent_app_date] => 2002-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 17
[patent_no_of_words] => 6905
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/482/07482506.pdf
[firstpage_image] =>[orig_patent_app_number] => 10472057
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/472057 | Ras p27 mouse models and uses thereof | Mar 25, 2002 | Issued |
Array
(
[id] => 6402431
[patent_doc_number] => 20020182192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'Methods for treating muscular dystrophy'
[patent_app_type] => new
[patent_app_number] => 10/100268
[patent_app_country] => US
[patent_app_date] => 2002-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7792
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20020182192.pdf
[firstpage_image] =>[orig_patent_app_number] => 10100268
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/100268 | Methods for treating muscular dystrophy | Mar 13, 2002 | Abandoned |
Array
(
[id] => 6110330
[patent_doc_number] => 20020172664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-21
[patent_title] => 'Methods of treating Parkinson\'s disease using recombinant adeno-associated virus virions'
[patent_app_type] => new
[patent_app_number] => 10/096723
[patent_app_country] => US
[patent_app_date] => 2002-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6761
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20020172664.pdf
[firstpage_image] =>[orig_patent_app_number] => 10096723
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/096723 | Methods of treating Parkinson's disease using recombinant adeno-associated virus virions | Mar 12, 2002 | Issued |
Array
(
[id] => 6051890
[patent_doc_number] => 20020170078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Calcineurin-related transgenic mammals, compositions and methods'
[patent_app_type] => new
[patent_app_number] => 10/091714
[patent_app_country] => US
[patent_app_date] => 2002-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12241
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20020170078.pdf
[firstpage_image] =>[orig_patent_app_number] => 10091714
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/091714 | Calcineurin-related transgenic mammals, compositions and methods | Mar 4, 2002 | Abandoned |
Array
(
[id] => 6741797
[patent_doc_number] => 20030159166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'H2-O modified transgenic animals'
[patent_app_type] => new
[patent_app_number] => 10/085297
[patent_app_country] => US
[patent_app_date] => 2002-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12286
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20030159166.pdf
[firstpage_image] =>[orig_patent_app_number] => 10085297
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/085297 | H2-O modified transgenic animals | Feb 27, 2002 | Abandoned |
Array
(
[id] => 5905779
[patent_doc_number] => 20020142338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-03
[patent_title] => 'Compositions and methods for inhibiting motor neuron degeneration'
[patent_app_type] => new
[patent_app_number] => 10/082032
[patent_app_country] => US
[patent_app_date] => 2002-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11583
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20020142338.pdf
[firstpage_image] =>[orig_patent_app_number] => 10082032
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/082032 | Compositions and methods for inhibiting motor neuron degeneration | Feb 20, 2002 | Abandoned |
Array
(
[id] => 6802503
[patent_doc_number] => 20030097668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Compositions and methods for the treatment and diagnosis of cardiovascular disease'
[patent_app_type] => new
[patent_app_number] => 10/067741
[patent_app_country] => US
[patent_app_date] => 2002-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 48198
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20030097668.pdf
[firstpage_image] =>[orig_patent_app_number] => 10067741
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/067741 | Compositions and methods for the treatment and diagnosis of cardiovascular disease | Feb 7, 2002 | Abandoned |